Tag Archives: SO

Best Warren Buffett Stocks To Buy Right Now

Since 2014 Hershey (NYSE:HSY) has been struggling a lot with its foreign operations. This has been due to the facts that the general business environment has been rather weak in foreign countries where Hershey is operating, that a strong dollar has hurt the sales and especially that the Chinese market has proved to be much more difficult than expected.

One other thing that I am even more worried about is the way the current management at Hershey is using adjusted earnings in its earnings releases. I do not know about the rest of the investors, but at least for me, when management is constantly talking about adjusted earnings instead of actual earnings, it is a warning sign. I can fully understand one-time business costs, such as transactions costs related to a major acquisition. In that type of a situation it is perfectly fine to use adjusted earnings because they give more visibility about the true earnings power of a company. However, when a company starts to constantly categorize regular annual costs as one-time costs, like Hershey is doing with business realignment costs, you should be very worried. In the case of Hershey, I would consider the business realignment costs as regular costs as they have been there for several years. This is a bit like when Warren Buffett is recommending that investors walk away if management is constantly referring to EBIT figures.

Best Warren Buffett Stocks To Buy Right Now: Conn's, Inc.(CONN)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co outperforming potential peersactive in electronics retailing such asmid capAaron’s, Inc (NYSE: AAN)and small cap CONN’S, Inc (NASDAQ: CONN):

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

  • [By Lisa Levin]

    Wednesday afternoon, the cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Conn's Inc (NASDAQ: CONN) and Wyndham Worldwide Corporation (NYSE: WYN).

Best Warren Buffett Stocks To Buy Right Now: Catalyst Biosciences, Inc. (CBIO)

Advisors’ Opinion:

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

  • [By Lisa Levin]

    Shares of Catalyst Biosciences Inc (NASDAQ: CBIO) were down around 27 percent to $5.36. Catalyst Biosciences reported the pricing of $18 million offering of Class A units at $5 per unit

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Best Warren Buffett Stocks To Buy Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Best Warren Buffett Stocks To Buy Right Now: Southern Company (The)(SO)

Advisors’ Opinion:

  • [By Dustin Parrett]

    Natural gas just claimed another victory over clean coal, as Southern Co. (NYSE: SO) announced on June 28 it’s converting its failed $7.1 billion clean coal power plant into a natural gas-fired facility.

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 1.9% Thursday and posted a new 52-week low of $45.08 after closing Wednesday at $45.96. The 52-week high is $53.51. Volume was about 5.4 million, about 15% above the daily average of around 4.8 million shares. The company had no specific news Thursday.

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 2.9% Wednesday and posted a new 52-week low of $45.81 after closing Tuesday at $47.20. The 52-week high is $53.51. Volume was about 5.5 million, about 15% above the daily average of around 4.8 million shares. The company had no specific news Wednesday.

  • [By ]

    Under a single-payer system, healthcare becomes a regulated utility much like electricity with just a few large, best-in-class players. Athenahealth (Nasdaq: ATHN) could combine with Walgreen Boots Alliance (NYSE: WBA). Maybe each monolith will cover a specific region like Southern Company (NYSE: SO) and Consolidated Edison (NYSE: ED).

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 1.7% Friday and posted a new 52-week low of $44.46 after closing Thursday at $45.25. The 52-week high is $53.51. Volume was over 6 million, about 20% above the daily average of around 4.8 million shares. The company was dropped from Neutral to Sell at Goldman Sachs on Thursday.

Best Warren Buffett Stocks To Buy Right Now: Westinghouse Air Brake Technologies Corporation(WAB)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Westinghouse Air Brake Technologies Corporation (WAB) scores highly based on my Warren Buffett-based model, which is based on the book Buffettology, and also the Peter Lynch-inspired approach that uses the method outlined by Lynch in One Up on Wall Street.

Best Warren Buffett Stocks To Buy Right Now: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
    Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
    Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
    Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
    Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
    Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
    AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
    Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
    Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
    Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

    Agence France-Presse/Getty Images

    The Patent Trial and Appeal Boardjust announced that CHRSs IPR on the 166 Humira formulation patent was not instituted. We remind investors that Amgens IPR on the same 157 and 158 formulation patents were also not instituted. Any at risk launch on a formulation that potentially infringes 166, 157 or 158 would seem unlikely and carries a high risk thatAbbVie would attain a preliminary injunction. It is not clear whether either company could attempt launch with a formulation that does not infringe the patent estate. We note that Sandoz has uniquely not filed any IPR on any biosimilars. Sandoz has not announced the FDA has accepted their filing for their biosimilar adalimumab…We anticipate that the perceived historic relationship of the immunogenicity of Humira as it relates to dose stretching will form a key debate in the ongoing PTAB case…

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

    Shares of AbbVie have climbed 5.6% to $59.18 at 3:05 p.m. today, while Coherus BioSciences has tumbled 11% to $25.18,Bristol-Myers Squibb has gained 3% to $52.56, andEli Lilly has risen 1.7% to $73.70.

  • [By Lisa Levin]

    Coherus Biosciences Inc (NASDAQ: CHRS) shares shot up 23 percent to $13.70 after the company announced plans to raise up to $150 million in a private placement.

Southern Company, Orchid Capital Drop into Thursday’s 52-Week Low Club

January 10, 2018: Here are four stocks trading with heavy volume among 40 equities making new 52-week lows in Thursday’s session. On the NYSE advancers led decliners by more than 3 to 1 and on the Nasdaq, advancers led decliners by the same margin.

Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) dropped more than 11% Thursday to post a new 52-week low of $0.31 after closing at $0.35 on Wednesday. The stock’s 52-week high is $2.18. Volume was around 5.5 million, more than double the daily average of around 2.3 million. The company had no specific news.

Orchid Island Capital Inc. (NYSE: ORC) fell about 9.7% to post a new 52-week low of $7.85 Thursday after closing at $8.69 on Wednesday. The 52-week high is $12.60. Volume of about 5.2 million was nearly 5 times the daily average of around 1.1 million. The company lowered its monthly dividend by 3 cents last night.

The Southern Co. (NYSE: SO) traded down about 1.9% Thursday and posted a new 52-week low of $45.08 after closing Wednesday at $45.96. The 52-week high is $53.51. Volume was about 5.4 million, about 15% above the daily average of around 4.8 million shares. The company had no specific news Thursday.

Colony NorthStar Inc. (NYSE: CLNS) dropped about 2.4% Thursday to post a 52-week low of $10.69 after closing at $10.95 on Wednesday. The 52-week high is $14.92. Volume was around 5.3 million, nearly double the daily average. The company had no specific news.

ALSO READ: Tech Industry Revenues to Reach $351 Billion This Year

10 Dividend Stocks You Can Set and Forget

Tired of keeping a close eye on financial news and popping in and out of positions in an effort to get the most out of an increasingly volatile market?

If so, you’re not alone. There is a solution, however, for investors who’ve become mentally exhausted thanks to a bull market that has now persisted for a stunning nine years — just buy some dividend stocks and stop watching the market every day. Go find a new hobby instead. With some stocks, you really are better off just leaving them alone and letting time do the hard work for you.

With that as the backdrop, if you don’t know how or where to start a hunt for new income-oriented holdings, here’s a look at ten great dividend stocks that would at home in almost any investor’s portfolio. They’re all more reliable than average, and represent companies that can weather almost any storm.

In no certain order…

Dividend Stocks to Buy: AT&T (T) Dividend Stocks to Buy: AT&T (T)investorplace.com/wp-content/uploads/2016/04/tmsn2-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/04/tmsn2-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/tmsn2-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/tmsn2-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/tmsn2-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/tmsn2-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/tmsn2-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/tmsn2-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/tmsn2-100×55.jpg 100w,https://investorplace.com/wp-content/uploads/2016/04/tmsn2-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/04/tmsn2-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/tmsn2-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Mike Mozart via Flickr

Dividend Yield: 5.3%

Telecom giant AT&T Inc. (NYSE:T) is an oldie but a goodie, and with uncharacteristic weakness from the stock since the middle of 2016, the dividend yield has been pumped up to an impressive 5.3%. That’s a dividend that has been paid every quarter for the past few decades, by the way, and raised like clockwork every year since 1984.

Sure, AT&T has got headaches right now, even beyond its usual competition. The deal to pair up with Time Warner Inc (NYSE:TWX) hasn’t exactly been smooth sailing. Industry insiders are relatively certain it’s going to happen despite the DOJ’s interference though, and in that AT&T is leading the race to make 5G connectivity a reality, it should be able to keep its wireless competitors in check at the same time it ramps up enrollments in its streaming cable service DirecTV Now.

AT&T looks to be firing on all cylinders.

Dividend Stocks to Buy: Blackstone Group (BX) Dividend Stocks to Buy: Blackstone Group (BX)investorplace.com/wp-content/uploads/2017/05/bxmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/05/bxmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/bxmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/bxmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/bxmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/bxmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/bxmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/bxmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/bxmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/05/bxmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Dividend Yield: 6.9% over the past 12 months

Blackstone Group LP (NYSE:BX) isn’t a traditional company. In fact, it’s not a company at all. It’s an organization that owns and financially supports a variety of other companies, and in some cases gets involved in the management of them. It’s a private equity firm, but it’s so much more than just that.

Additionally, it’s good at what it does, and that’s good for income-seeking investors. While the dividend payout can vary unpredictably from one quarter to the next, broadly speaking it has been on the rise for quite some time, and a dividend of some sort has always been dished out. And if the economy heats and up in interest rates rise, much like a bank, that’s very good for Blackstone’s bottom line as it will eventually makes its way back into the pocket of shareholders.

The dividend yield of 6.8% over the last year, in the meantime, isn’t too shabby either.

Dividend Stocks to Buy: AmTrust Financial Services (AFSI) Dividend Stocks to Buy: AmTrust Financial Services (AFSI)investorplace.com/wp-content/uploads/2016/05/cashmsn2-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/05/cashmsn2-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/05/cashmsn2-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/05/cashmsn2-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/05/cashmsn2-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/05/cashmsn2-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/05/cashmsn2-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/05/cashmsn2-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/05/cashmsn2-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: 401(K) 2012 via Flickr (Modified)

Dividend Yield: 6.6%

There aren’t any kinds of insurance AmTrust Financial Services Inc (NASDAQ:AFSI) doesn’t offer. In fact, life and health insurance are the only two major insurance markets AmTrust doesn’t dabble in.

That’s a two-edged sword, mind you. While the company has sidestepped the debacle of the ramifications of the Affordable Care Act and now the (more or less) end of it, Amtrust’s heavy reliance on catastrophic insurance policies meant it took a big hit when hurricanes Harvey and Irma took aim at the United States during the fall of last year. All told, the insurer swung from a profit of 61 cents per share in the same quarter a year ago to a loss of four cents per share in Q3 of 2017.

The resulting beat-down wasn’t necessary though, as it founded on a catastrophe the likes of which are rarely seen. The strong selloff from AFSI, however, has cranked its dividend yield up to a still-sustainable 6.6%.

Dividend Stocks to Buy: UBS Group (UBS) Dividend Stocks to Buy: UBS Group (UBS)investorplace.com/wp-content/uploads/2017/05/ubsmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/05/ubsmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/ubsmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/ubsmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/ubsmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/ubsmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/ubsmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/ubsmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/ubsmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/05/ubsmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Dividend Yield: 3.2%

When investors go on the hunt for dividend stocks within the financial sector, Zurich-based UBS Group AG (USA) (NYSE:UBS) usually isn’t a top-of-mind name. It should be though, now more than ever … It not only had a 3.2% yield, but also a 26-cent special dividend paid out in the past year.

There’s room for dividend growth too. Analysts are looking for 2017 earnings of $1.28 per share, up from 2016’s $1.17, which is projected to grow to $1.50 in 2018. And, only about 57% of its profits are currently being passed along to shareholders as dividends.

Dividend Stocks to Buy: Two Harbors (TWO) Dividend Stocks to Buy: Two Harbors (TWO)investorplace.com/wp-content/uploads/2017/10/mortgagemsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/10/mortgagemsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/10/mortgagemsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/10/mortgagemsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/10/mortgagemsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/10/mortgagemsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/10/mortgagemsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/10/mortgagemsn-91×50.jpg 91w,https://investorplace.com/wp-content/uploads/2017/10/mortgagemsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/10/mortgagemsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: House Buy Fast via Flickr

Dividend Yield: 11.9%

Two Harbors Investment Corp (NYSE:TWO) is anything but a household name. It’s not even a company. It’s an investment company, organized as a REIT, and is an obscure one at that. Don’t let the obscurity fool you though. There’s a lot of reliability packed into this obscure mortgage REIT package too, all the way back to 2010.

More important, things could heat up for this outfit sooner than most people are expecting. As Chief Investment Officer Bill Roth commented within the last quarterly report, “We are very excited about the opportunities we see emerging for our business. With the Fed reducing their reinvestments in Agency RMBS and mortgage spreads likely to widen, owning MSR is a significant benefit to our portfolio. Yet, at wider spreads, we believe there could be a tremendous investment opportunity to add Agencies.”

It’s currently yielding 11.9%.

Dividend Stocks to Buy: Iron Mountain (IRM) Dividend Stocks to Buy: Iron Mountain (IRM)investorplace.com/wp-content/uploads/2016/06/irmmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/06/irmmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/06/irmmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/06/irmmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/06/irmmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/06/irmmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/06/irmmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/06/irmmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/06/irmmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw,728px” />Source: Orin Zebest via Flickr

Dividend Yield: 6.3%

In a world that’s increasingly centered on the digital cloud, one would think the printed documents and literal signatures on forms would be a thing of the past. And to a large degree, things are moving in that direction. If you think paper is a thing of the past though, think again. The world is still printing like crazy, and organizations still need to store it all for a myriad of reasons.

Enter Iron Mountain Incorporated (Delaware) REIT (NYSE:IRM), which as its name implies, offers secure storage of physical files for organizations that are legally required to retain them. Iron Mountain helps companies make the move from physical to digital document management, helping them solve tricky compliance problems along the way.

It even offers document shredding solutions. In all cases though, it’s a wonderful recurring revenue business, easily supporting the dividend yield of 6.3%. That dividend grows pretty regularly too.

Dividend Stocks to Buy: BP (BP) Dividend Stocks to Buy: BP (BP)investorplace.com/wp-content/uploads/2017/05/bpmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/05/bpmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/bpmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/bpmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/bpmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/bpmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/bpmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/bpmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/bpmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/05/bpmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Dividend Yield: 5.6%

The future of BP Plc (ADR) (NYSE:BP) has more to do with the price of oil than how well the company itself is managed. But, both bode well for the company. Oil prices have rallied from less than $30 per barrel in early 2016 to a current price near $60 now, and though a little profit-taking is in the cards, the broad undertow remains a bullish one.

Crude’s rebound couldn’t have come at a better time for BP either. As of October, the dividend was and was expected to remain above per-share earnings. With crude well above BP’s breakeven price of around $47 as of August though, margins should start to widen quite nicely and leave decent-sized profit cushion for that dividend yield of 5.6%.

Dividend Stocks to Buy: Southern (SO) Dividend Stocks to Buy: Southern (SO)investorplace.com/wp-content/uploads/2016/04/somsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/04/somsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/somsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/somsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/somsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/somsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/somsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/somsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/somsn-100×55.jpg 100w,https://investorplace.com/wp-content/uploads/2016/04/somsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/04/somsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/somsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Desiree Kane via Flickr

Dividend Yield: 5%

No list of dividend stocks to buy would be complete without a utility stock, and no list of ownership-worthy utility stocks would omit Southern Co (NYSE:SO).

As to the former, utility stocks are cash-flow machines. In good economic times as well as bad, at a very minimum consumers keep their lights on by forking money over to their power supplier every month. As to the latter, Southern serves a total of 9 million customers peppered all across the nation, with plenty of exposure in the south and along the east coast. That kind of scale means a lot in the utility business.

It also smooths out any bumps and rough patches that could otherwise jeopardize its yield of 5%. It’s been reliably paid and steadily rising since 1948.

Dividend Stocks to Buy: Park Hotels & Resorts (PK) Dividend Stocks to Buy: Park Hotels & Resorts (PK)investorplace.com/wp-content/uploads/2016/09/officereitmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/09/officereitmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/09/officereitmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/09/officereitmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/09/officereitmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/09/officereitmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/09/officereitmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/09/officereitmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2016/09/officereitmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Anders Jildén via Unsplash

Dividend Yield: 7.7%

The name Park Hotels & Resorts Inc (NYSE:PK) may not ring a bell, but some of the hotels owned by this REIT will. It owns and operates, among others, several Hiltons, boasting 67 locales and 35,000 rooms… most aimed at the upper-scale traveler.

It doesn’t necessarily seem like the steadiest market to be in, but it’s more stable than one might imagine. A huge chunk of its hotels are in important business districts, and if the economy takes off the way it looks like it’s going to take off, that will keep Park Hotels & Resorts plenty busy for some time. Even if the economy doesn’t quite turn red-hot though, the yield of 7.7% is relatively well protected.

Dividend Stocks to Buy: Pfizer (PFE) Dividend Stocks to Buy: Pfizer (PFE)investorplace.com/wp-content/uploads/2017/10/pfemsn-300×150.jpg 300w, investorplace.com/wp-content/uploads/2017/10/pfemsn-768×384.jpg 768w, investorplace.com/wp-content/uploads/2017/10/pfemsn-60×30.jpg 60w, investorplace.com/wp-content/uploads/2017/10/pfemsn-200×100.jpg 200w, investorplace.com/wp-content/uploads/2017/10/pfemsn-400×200.jpg 400w, investorplace.com/wp-content/uploads/2017/10/pfemsn-116×58.jpg 116w, investorplace.com/wp-content/uploads/2017/10/pfemsn-100×50.jpg 100w, investorplace.com/wp-content/uploads/2017/10/pfemsn-78×39.jpg 78w, investorplace.com/wp-content/uploads/2017/10/pfemsn-800×400.jpg 800w,https://investorplace.com/wp-content/uploads/2017/10/pfemsn-170×85.jpg 170w” sizes=”(max-width: 950px) 100vw, 950px” />Source: Shutterstock

Dividend Yield: 3.7%

Last but not least, the 3.7% yield Pfizer Inc. (NYSE:PFE) currently offers doesn’t necessarily put it in the top echelon of dividend stocks, but what it lacks in income-producing potential it balances out with lots of growth potential.

One of those growth engines is Eucrisa. As Chris Lau pointed out last month, 60% of eczema patients using the treatment are repeat buyers. It could be a $2 billion drug at its peak pace. Meanwhile, arthritis drug Xeljanz is slated for an approval decision in March. Both offer new revenue stream potential.

In the meantime, its existing portfolio of products will continue to drive cash flow that funds what it pays back out to shareholders. This is the same company that owns staples like Advil as well as Lyrica, for the treatment of diabetic nerve pain and fibromyalgia.

Pfizer’s going to be fine.

As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can follow him on Twitter, at @jbrumley.

Compare Brokers

Top 10 Medical Stocks To Watch For 2018

Gladstone, NJ, based Investment company Murphy Capital Management Inc buys SPDR Select Sector Fund – Consumer Discretionary, Bristol-Myers Squibb Company, SPDR Select Sector Fund – Industrial, Lear, OSI Systems, SPDR Select Sector Fund – Consumer Staples, Siemens AG, CBS, iShares MSCI Emerging Index Fund, FedEx, sells Xylem, Time Warner, St Jude Medical, Mead Johnson Nutrition Co, Becton, Dickinson and Co during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Murphy Capital Management Inc. As of 2017-03-31, Murphy Capital Management Inc owns 266 stocks with a total value of $660 million. These are the details of the buys and sells.

New Purchases: LEA, OSIS, CBS, FEZ, ACWI, ACIA, CNC, ETN, GLW, ADBE, Added Positions: XLY, BMY, XLI, XLP, SIEGY, AMZN, FB, EEM, FDX, FEU, Reduced Positions: AAPL, XYL, TWX, BDX, SBUX, HD, UPS, XLV, DIS, EL, Sold Out: STJ, MJN, JCI, GATX, GPC, BT, PX, TM, OKE, OTEX,

For the details of MURPHY CAPITAL MANAGEMENT INC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=MURPHY+CAPITAL+MANAGEMENT+INC

Top 10 Medical Stocks To Watch For 2018: iShares Core S&P Mid-Cap (IJH)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Lubar & Co., Inc’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Lubar+%26+Co.%2C+Inc

    These are the top 5 holdings of Lubar & Co., IncEnLink Midstream LLC (ENLC) – 1,882,007 shares, 37.97% of the total portfolio. Shares added by 0.40%Hallador Energy Co (HNRG) – 2,788,685 shares, 23.23% of the total portfolio. Vanguard Value ETF – DNQ (VTV) – 77,126 shares, 7.65% of the total portfolio. iShares Core S&P Mid-Cap (IJH) – 38,400 shares, 6.84% of the total portfolio. New PositionVanguard Mid-Cap Value ETF – DNQ (VOE) – 61,550 shares, 6.52% of the tota

Top 10 Medical Stocks To Watch For 2018: CRH Medical Corporation(CRHM)

Advisors’ Opinion:

  • [By Lisa Levin]

    CRH Medical Corp (NYSE: CRHM) was down, falling around 31 percent to $2.55 after the company disclosed financial and operating results for the quarter and six months ended June 30, 2017.

Top 10 Medical Stocks To Watch For 2018: 3M Company(MMM)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Who are the likely candidates for the next round of upgrades? Cramer said he’s betting that 3M (MMM) will be in the mix, along with Walmart (WMT) and especially Home Depot (HD) , which should have a strong spring planting season with good comparisons to last year. Investors might also see upgrades on Honeywell (HON) and Nike (NKE) , Cramer suggested.

  • [By Lisa Levin]

    3M Co (NYSE: MMM) agreed to sell substantially all of its communication markets division to Corning Incorporated (NYSE: GLW) for $900 million.

    Corning expects the deal adding $0.07 to $0.09 per share in FY19 earnings.

  • [By Shanthi Rexaline]

    Here is the list of the Dow components, which are scheduled to report this week:

    1. 3M Co
    Company: 3M Co (NYSE: MMM). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $2.54 versus $2.08. Revenue Estimate: $7.86 billion versus $7.66 billion. Stock Gain/Loss (year to date): 18.12 percent.
    2. Caterpillar
    Company: Caterpillar Inc. (NYSE: CAT). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.25 versus $1.09. Revenue Estimate: $10.93 billion versus $10.94 billion. Stock Gain/Loss (year to date): 16.10 percent.
    3. McDonald’s
    Company: McDonald’s Corporation (NYSE: MCD). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.62 versus $1.45. Revenue Estimate: $5.96 billion versus $6.26 billion. Stock Gain/Loss (year to date): 25.35 percent.
    4. United Technologies
    Company: United Technologies Corporation (NYSE: UTX) Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.78 versus $1.82. Revenue Estimate: $15.24 billion versus $14.87 billion. Stock Gain/Loss (year to date): 12.47 percent.

    See also: 3 Reasons Alcoa Is No Longer The Curtain-Raising Event Of Earnings Season

Top 10 Medical Stocks To Watch For 2018: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ: APOP) shares were also up, gaining 135 percent to $7.79 after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.

  • [By Chris Lange]

    Cellect Biotechnology Ltd. (NASDAQ: APOP) reported that it received a formal notice from the U.S. Patent and Trademark Office (USPTO)regarding its method of treatment for immune related disorders. Basically, the USPTO gave a notice of allowance which broadly means the agency intends to issue a patent approval. The treatment method relates to the engineering of regulatory immune cells with enhanced apoptotic activity used for the treatment or prevention for the unmet needs seen in type 1 diabetes, inflammatory bowel disease, graft versus host disease, and transplant rejection.

Top 10 Medical Stocks To Watch For 2018: Unifi, Inc.(UFI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Unifi, Inc. (NYSE: UFI) shares were also up, gaining 18 percent to $26.92 as the company announced Q3 earnings of $0.56 per share on revenue of $161.3 million.

Top 10 Medical Stocks To Watch For 2018: Southern Company (The)(SO)

Advisors’ Opinion:

  • [By Ben Levisohn]

    For those that are looking to express a more downbeat market view, or looking for a source of funds, we can neutralize our positive S&P 500 outlook and aim to sell stocks that are at risk to underperform on a relative basis. While a rising tide lifts all boats in absolute terms, we found that mega-cap safety is the central theme linking stocks that are at, or nearing, decade-long relative lows vs. the S&P 500: General Electric, Southern (SO), Simon Property Group (SPG), Verizon Communications (VZ), Wal-Mart, ExxonMobil. We see such relative weakness as a sign of vulnerability in their trend.

  • [By ]

    Under a single-payer system, healthcare becomes a regulated utility much like electricity with just a few large, best-in-class players. Athenahealth (Nasdaq: ATHN) could combine with Walgreen Boots Alliance (NYSE: WBA). Maybe each monolith will cover a specific region like Southern Company (NYSE: SO) and Consolidated Edison (NYSE: ED).

  • [By WWW.MONEYSHOW.COM]

    Southern Company (SO) produces 44,000 megawatts of generating capacity and 1,500 billion cubic feet of combined natural gas consumption and throughput volume.

Top 10 Medical Stocks To Watch For 2018: MDC Partners Inc.(MDCA)

Advisors’ Opinion:

  • [By Lisa Levin]

    MDC Partners Inc (NASDAQ: MDCA) shares dropped 60 percent to $3.38. MDC Partners reported a Q3 loss of $0.64 per share on revenue of $349.3 million.

  • [By Lisa Levin]

    Shares of MDC Partners Inc (NASDAQ: MDCA) were down 31 percent to $12.52 after the company posted downbeat quarterly results and lowered its FY16 sales outlook.

Top 10 Medical Stocks To Watch For 2018: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Chris Lange]

    T-Mobile US, Inc. (NASDAQ: TMUS) reported first quarter financial results after markets closed Monday. The company said that it had $0.80 in diluted GAAP earnings per share (EPS) and $9.61 billion in revenue, versus consensus estimates from Thomson Reuters that called for $0.34 in EPS and $9.62 billion in revenue. The same period from last year had $0.56 in EPS and $8.6 billion in revenue.

  • [By WWW.THESTREET.COM]

    Donald Trump’s election has proved a boon for shareholders of Sprint (S) , on the premise that a Republican administration would be open to a merger of the carrier to T-Mobile USA (TMUS) . Regulators under Obama had pushed back against Sprint Chairman Masayoshi Son’s goal of combining the U.S.’s third- and fourth-largest carriers.

  • [By Money Morning Staff Reports]

    SoftBank also purchased telecom upstart Sprint Corp. (NYSE: S) in 2013. And it is considering deals with other communications giants, including Charter Communications Inc. (Nasdaq: CHTR) and T-Mobile U.S. Inc. (Nasdaq: TMUS)

Top 10 Medical Stocks To Watch For 2018: Affimed N.V.(AFMD)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares rose 47.1 percent to $3.22 in pre-market trading after jumping 54.23 percent on Wednesday.
    Digital Power Corporation (NYSE: DPW) rose 27.6 percent to $0.800 in pre-market trading after gaining 9.79 percent on Wednesday.
    Social Reality Inc (NASDAQ: SRAX) shares rose 23.1 percent to $7.16 in the pre-market trading session after surging 37.59 percent on Wednesday.
    China Auto Logistics Inc (NASDAQ: CALA) rose 16.9 percent to $4.15 in pre-market trading after gaining 4.11 percent on Wednesday.
    Riot Blockchain Inc (NASDAQ: RIOT) rose 15.1 percent to $18.40 in pre-market trading after climbing 42.01 percent on Wednesday.
    Seven Stars Cloud Group Inc (NASDAQ: SSC) rose 14.5 percent to $2.85 in the pre-market trading session after gaining 0.40 percent on Wednesday.
    Affimed NV (NASDAQ: AFMD) shares rose 14.3 percent to $2.40 in pre-market trading after gaining 4.88 percent on Wednesday.
    Corecivic Inc (NYSE: CXW) rose 10.2 percent to $25.56 in pre-market trading after climbing 0.65 percent on Wednesday.
    LM Funding America, Inc. (NASDAQ: LMFA) rose 9.6 percent to $3.30 in pre-market trading after surging 34.98 percent on Wednesday.
    U.S. Global Investors, Inc. (NASDAQ: GROW) rose 7.2 percent to $3.30 in pre-market trading after dropping 8.06 percent on Wednesday.
    Xunlei Ltd (NASDAQ: XNET) rose 6.8 percent to $25.61 in pre-market trading after climbing 11.74 percent on Wednesday.
    Net 1 UEPS Technologies Inc (NASDAQ: UEPS) shares rose 5.9 percent to $13.00 in pre-market trading after gaining 21.34 percent on Wednesday.
    Addus Homecare Corporation (NASDAQ: ADUS) rose 5.5 percent to $35.60 in pre-market trading after gaining 3.69 percent on Wednesday.
    TOP SHIPS Inc (NASDAQ: TOPS) rose 5.2 percent to $0.528 in pre-market trading after falling 10.36 percent on Wednesday.
    Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) rose 4.7 percent to $14.11 in pre-market trading. Teva Pharma
  • [By Lisa Levin]

    Shares of Affimed NV (NASDAQ: AFMD) were down around 21 percent to $1.70. Affimed priced its public offering of 10,000,000 of its common shares at $1.80 per common share.

Top 10 Medical Stocks To Watch For 2018: Geopark Ltd(GPRK)

Advisors’ Opinion:

  • [By Dustin Parrett]

    As a service to our readers, we’ve put together a list of 10 cheap oil stocks under $5. Here are the stocks, share prices, and year-to-date (YTD) returns for each:

    Vallourec Sp (OTCMKTS ADR: VLOWY); $1.42; +13.6% YTDIthaca Energy Inc. (TSE: IAE); $1.93; +14.5% YTDSandRidge Permian Trust (NYSE: PER); $3.45; +16.95% YTDGeopark Ltd. (NYSE: GPRK); $5.06; +17.4% YTDGastar Exploration Inc. (NYSEMKT: GST); $1.89; +22.26% YTDAscent Resources Plc. (LON: AST); $2.11; +25.53% YTDErin Energy Corp. (NYSEMKT: ERN); $3.94; +29.1% YTDChesapeake Granite Wash Trust (NYSE: CHKR); $3.25; +38.3% YTDSouthcross Energy Partners LP (NYSE: SXE); $2.27; +68.15% YTDBonanza Creek Energy Inc. (NYSE: BCEI); $2.27; +122.55% YTD

    This list of oil stocks contains some highly speculative plays, so we can’t recommend buying them.

12 Best Dividend Stocks for the Next 12 Months

Finding the best dividend stocks involves looking beyond the next few weeks and thinking about a long-term investment. After all, if you’re only in a dividend stock for a short time then you may not get the full yield that’s based on a full year of payouts.

And heck, if you don’t pay attention to dividend dates, you may not get a single payment!

It’s much better, then, to focus on the best dividend stocks for the next year instead of just the next month. That is the only way to ensure that you get a full battery of payments from your investments, and that you maximize the income potential of your portfolio.

In truth, all investors are too short-sighted with their portfolios. They fear short-term volatility, and make rash decisions. But particularly if you’re a dividend investor, thinking in any less than 12-month increments can be very detrimental to your performance.

To help you make the most of 2018, then, here are 12 dividend stocks that will continue to profit for the next 12 months, not just the short term.

Dividend Stocks to Buy Now: Enterprise Products Partners (EPD) Dividend Stocks to Buy Now - Enterprise Products Partners (EPD)investorplace.com/wp-content/uploads/2016/05/epdmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/05/epdmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/05/epdmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/05/epdmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/05/epdmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/05/epdmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/05/epdmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/05/epdmsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/05/epdmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Bilfinger via Flickr
Sector: Energy Market Cap: $52 billion Yield: 7% YTD Return: -10% vs. 17% for the S&P 500

Pipeline operator Enterprise Products Partners L.P. (NYSE:EPD) is a great example of the income potential in energy stocks. While exploration and production companies have to take on big debts on the hopes that they will strike enough oil to turn a profit, EPD is just a middleman between those producers and the marketplace. That insulates it from the volatility of energy prices, and allows for a more reliable revenue stream.

In addition to the reliable revenue stream of its business, EPD also boasts an impressive scale that should be attractive to low-risk investors. The energy company operates more than 49,000 miles of pipeline, 260 million barrels of crude oil storage and another 14 billion cubic feet of natural gas storage.

Currently, Enterprise Products offers a great yield of 7%, and has a strong track record of raising distributions over time, too. It’s this constant and growing payout that is the hallmark of a good MLP investment.

Dividend Stocks to Buy Now: Ladder Capital (LADR) Dividend Stocks to Buy Now: Ladder Capital (LADR)investorplace.com/wp-content/uploads/2016/09/reitmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/09/reitmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/09/reitmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/09/reitmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/09/reitmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/09/reitmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/09/reitmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/09/reitmsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/09/reitmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Yuriy Trubitsyn via Unsplash
Sector: REITs Market Cap: $2 billion Yield: 9.2% YTD Return: 1% vs. 17% for the S&P 500

Ladder Capital Corp (NYSE:LADR) is not your typical real estate investment trust. Unlike other stocks that own shopping malls or office parks, LADR doesn’t own physical properties. Instead, it invests as a third party in these real estate holdings either through lending, equity investments or other financing.

This makes Ladder Capital more of a financial stock than a real estate play in a way, since its stock is tied to the performance of its underlying investments in properties. But the difference is that while banks can operate with a bit more flexibility, the designation as an REIT demands that the firm delivers 90% of taxable income back to shareholders. That is a mandate for big dividends, with LADR being a pass-through for shareholders who want to share in the fruits of its investments.

Those investments are looking pretty strong, too, with loans and investment in properties that span the country from New York to L.A. Those deals collectively deliver a more than 9% dividend to shareholders via the interest on those loans and other capital appreciation. And as the American economy continues to thrive with low unemployment, high consumer confidence and a roaring stock market, these investments are sure to keep delivering.

This is a great cyclical dividend play for the next few years as a result of rising rents and property values in 2018.

Dividend Stocks to Buy Now: AbbVie (ABBV) Dividend Stocks to Buy Now: AbbVie (ABBV)investorplace.com/wp-content/uploads/2016/04/abbvmsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-91×50.jpg 91w,https://investorplace.com/wp-content/uploads/2016/04/abbvmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/abbvmsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/04/abbvmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Black Stripe via Wikimedia (Modified)
Sector: Healthcare Market Cap: $153 billion Yield: 3% YTD Return: 52% vs. 17% for the S&P 500

AbbVie Inc (NYSE:ABBV) was spun off of Big Pharma mainstay Abbott Laboratories (NYSE:ABT) in 2013, and it is the drug-focused arm of the previous company. It’s home to current blockbusters, including psoriasis treatment Humira as well as a research-driven drugmaker looking for the next generation of big-name cures.

Analysts are projecting revenue growth at ABBV of almost 10% this year and next, and profit expansion of 15% or better both years thanks to a strong pharmaceutical portfolio. And that success has translated into generous dividends, as the company has ramped up its payout from 40 cents after its initial spin-off to 64-cents-per-share just four years later.

With decent profit growth resulting in continued dividend growth, investors can enjoy not just a robust payout now, but the hopes of continued payouts from this healthcare giant going forward.

Dividend Stocks to Buy Now: Southern Company (SO) Dividend Stocks to Buy Now: Southern Company (SO)investorplace.com/wp-content/uploads/2016/04/somsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/somsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/somsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/somsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/somsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/somsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/somsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/somsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/04/somsn-91×50.jpg 91w,https://investorplace.com/wp-content/uploads/2016/04/somsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/somsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/04/somsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Desiree Kane via Flickr
Sector: Utilities Market Cap: $51 billion Yield: 4.5% YTD Return: 4% vs. 17% for the S&P 500

Southern Co (NYSE:SO) is one of the largest utilities in the U.S., serving 19 states through various subsidiaries. While its oldest core holdings, including Alabama Power and Georgia Power, are electric utilities, the company’s Southern Company Gas operates a massive natural gas distribution business from Maryland to Florida and its Southern Telecom is a play on fiber optics in the Southeast as well.

SO stock offers scale and stability, and is a consistent dividend payer that has mailed check to shareholders since 1982. On top of that, Southern Company has raised dividend payouts at least once each year since 2001 even as it has continued to expand aggressively into other businesses and geographies.

Utility stocks are some of the safest bets out there thanks to geographic monopolies and a highly regulated industry that doesn’t allow for new entrants or much competition. As one of the nation’s leading utilities with a reliable customer base, SO is sure to prosper in 2018.

Dividend Stocks to Buy Now: Phillips 66 Partners (PSXP) Dividend Stocks to Buy Now – Phillips 66 Partners (PSXP)investorplace.com/wp-content/uploads/2017/05/oilmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/oilmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/oilmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/oilmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/oilmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/oilmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/oilmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/oilmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/05/oilmsn-170×93.jpg170w, investorplace.com/wp-content/uploads/2017/05/oilmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Shutterstock
Sector: Energy Market Cap: $5 billion Yield: 5.8% YTD Return: -7% vs. 17% for the S&P 500

Many of the most successful MLPs have been created by large energy companies that want the benefit from the unique structure of this kind of business. It’s often a win-win for both the primary stock that is the general partner as well as for the new partnership that has been created, and that’s exactly the case with Phillips 66 Partners LP (NYSE:PSXP) and its corporate parent ConocoPhillips (NYSE:COP).

Spun off in 2013, Phillips 66 Partners consists of pipelines, terminals and other midstream assets that help power the broader ConocoPhillips business. The tax benefits and a generous yield of over 5% kicked back to COP as a major investor make it great for the parent, but the MLP benefits nicely too. Consider PSXP received more than $2.3 billion in projects from its parent company last year alone!

Phillips 66 Partners has raised its distribution for 16 consecutive quarters since entering public markets, and is clearly committed to delivering consistent income to its shareholders.

Dividend Stocks to Buy Now: Medical Properties Trust (MPW) Dividend Stocks to Buy Now – Medical Properties Trust (MPW)investorplace.com/wp-content/uploads/2017/09/mpwmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/09/mpwmsn-170×93.jpg170w, investorplace.com/wp-content/uploads/2017/09/mpwmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Shutterstock
Sector: REITs Market Cap: $5 billion Yield: 7% YTD Return: 12% vs. 17% for the S&P 500

Medical Properties Trust, Inc. (NYSE:MPW) is a fast-growing REIT seeing brisk expansion of its funds from operations — the most important measure we can get from this special class of tax-sheltered companies. That reliable and growing flow of cash also helps fuel reliable and growing dividends, to the tune of 7% currently.

But it’s not just the income potential that’s worth a look here. Aging baby boomers are increasing demand for care in the U.S., inflationary trends guarantee pricing power in the sector, and even in an economic downturn you’ll see Americans cut back on everything but their healthcare.

MPW is well-positioned to capitalize on this trend thanks to its ownership of community hospitals and acute-care centers — and a recent acquisition of 11 more facilities will certainly boost its numbers in the year ahead.

Dividend Stocks to Buy Now: Altria (MO) Dividend Stocks to Buy Now: Altria (MO)investorplace.com/wp-content/uploads/2016/05/momsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/05/momsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/05/momsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/05/momsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/05/momsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/05/momsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/05/momsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/05/momsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/05/momsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Peyri Herrera via Flickr (Modified)
Sector: Consumer staples Market Cap: $129 billion Yield: 3.9% YTD Return: -2% vs. 17% for the S&P 500

Altria Group Inc (NYSE:MO) may strike some as a no-growth company without much upside. However, this pick is not just a dividend stock; consider that over the past five years, it has actually outperformed the S&P 500 in share price performance alone thanks to aggressive buybacks and shrewd management of profitability.

And of course, MO stock is a go-to for dividend investors after 48 consecutive years of increases in its payout. Those increases aren’t a penny here and there, either — as evidenced most recently with an 8% bump in 2017 from 61 cents to 66 cents.

Yes, traditional tobacco products are on the outs. But keep in mind that Altria is not merely Philip Morris USA — the name behind iconic cigarette brands like Marlboro and Parliament. Altria also dabbles in smokeless products and even wines via producer Ste. Michelle. This provides an added level of long-term stability.

Shares haven’t done much lately in 2017, but with a forward price-to-earnings ratio of less than 18 and reliable profit growth ahead in 2018, I’d bank on Altria regardless of short-term market trends.

Dividend Stocks to Buy Now: Cisco (CSCO) Dividend Stocks to Buy Now: Cisco (CSCO)investorplace.com/wp-content/uploads/2017/05/cscomsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/cscomsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/cscomsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/cscomsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/cscomsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/cscomsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/cscomsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/cscomsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/05/cscomsn-170×93.jpg 170w,https://investorplace.com/wp-content/uploads/2017/05/cscomsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Shutterstock
Sector: Technology Market Cap: $186 billion Yield: 3.1% YTD Return: 25% vs. 17% for the S&P 500

When investors look for reliable dividend stocks, often they overlook the tech sector. That’s in part because even tech companies like Apple Inc. (NASDAQ:AAPL) that pay some kind of dividend still offer less than 10-year Treasuries — or on the flip side, because many tech stocks that do yield a decent amount don’t have much to offer investors beyond their dividends.

But Cisco Systems, Inc. (NASDAQ:CSCO) stands apart. Not only does the IT giant currently offer an attractive dividend, with payouts that have jumped from 6 cents in 2011 to 29 cents a quarter at present, it also has a good growth story to tell after an impressive earnings report before Thanksgiving. Not only did it beat on earnings and boost its outlook, but the company showed Wall Street it is effectively transitioning away from networking hardware and into cloud-based solutions that are the norm in 2017. Shares are up about 20% in the last three months as a result.

These structural improvements at CSCO bode well for 2018 and beyond. And given Cisco’s commitment to increased dividends and deep pockets with some $72 billion in cash and investments in the bank, you can be certain this company will keep rewarding shareholders for the next decade to come.

Dividend Stocks to Buy Now: Diageo (DEO) Dividend Stocks to Buy Now: Diageo (DEO)investorplace.com/wp-content/uploads/2016/05/deomsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/05/deomsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/05/deomsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/05/deomsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/05/deomsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/05/deomsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/05/deomsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/05/deomsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/05/deomsn.jpg 728w” sizes=”(max-width: 300px)100vw, 300px” />Source: Puamella via Flickr (Modified)
Sector: Consumer staples Market Cap: $87 billion Yield: 2.3% YTD Return: 35% vs. 17% for the S&P 500

Diageo plc (ADR) (NYSE:DEO) is a world leader in the spirits business, with mega-brands including Johnnie Walker whisky, Smirnoff vodka, Tanqueray and Guinness beer, among a host of others. And thanks to a focus mainly on liquor, DEO stock has been largely insulated from the shakeup we’ve seen in the beer biz as craft brews have eroded share.

For instance, even as Anheuser Busch InBev NV (ADR) (NYSE:BUD) has struggled since 2015 despite a $200 billion operation with some of the biggest mainline beers on the planet, Diageo has slightly outperformed the market thanks to modest but consistent growth.

As a “sin stock,” Diageo also has the unique benefit of seeing stable or even increased demand during hard times. After all, why give up your cocktails if the market is crashing, hurricanes are bearing down on your house and North Korea is thinking of detonating a nuke?

Dividend Stocks to Buy Now: Dominion Energy (D) Dividend Stocks to Buy Now: Dominion Energy (D)investorplace.com/wp-content/uploads/2016/12/energy-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/12/energy-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/12/energy-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/12/energy-400×220.jpg 400w, investorplace.com/wp-content/uploads/2016/12/energy-116×64.jpg 116w, investorplace.com/wp-content/uploads/2016/12/energy-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/12/energy-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/12/energy-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/12/energy-170×93.jpg 170w,https://investorplace.com/wp-content/uploads/2016/12/energy.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Riccardo Annandale Via Unsplash
Sector: Utilities Market Cap: $52 billion Yield: 3.7% YTD Return: -10% vs. 17% for the S&P 500

Dominion Energy Inc (NYSE:D) is a safe play for a host of reasons. But chief among them are the facts that it is a low-risk utility stock with reliable operations and a significant yield.

Dominion generates electricity mainly in the mid-Atlantic region of the U.S. from North Carolina to Pennsylvania and distributes natural gas across a wide swath of the American West. The consistent cash flow from these operations has fueled consistent dividend payouts for almost 90 years, and has allowed Dominion to grow payouts substantially over time; distributions were 39.5 cents quarter at the end of 2008 and are now 77 cents, an increase of about 95% in about nine years.

The icing on the cake is that Dominion is one of the most adaptable and diversified utilities in the U.S., with numerous nuclear and renewable power generation facilities in its portfolio. This isn’t just good as a hedge against the long-term decline of fossil fuels, but also a bridge to new business. One recent headline that should really pique investor interest is a recent contract to provide renewable energy to a Facebook Inc (NASDAQ:FB) data center in Virginia.

That kind of willingness to meet big corporations where they live is a strong sign that Dominion is forward-thinking and isn’t just sitting back collecting monthly checks from customers.

Dividend Stocks to Buy Now: Merck (MRK) Dividend Stocks to Buy Now: Merck (MRK)investorplace.com/wp-content/uploads/2017/10/mrkmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/10/mrkmsn-170×93.jpg 170w,https://investorplace.com/wp-content/uploads/2017/10/mrkmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Shutterstock
Sector: Healthcare Market Cap: $151 billion Yield: 3.4% YTD Return: -6% vs. 17% for the S&P 500

Merck & Co., Inc. (NYSE:MRK) continues to see growth as its drugs look to fight common American health conditions. Its blockbuster diabetes drug Januvia, which helps lower blood sugar, accounts for some $4 billion in annual sales and its Zetia cholesterol medication racks up over $2 billion in annual sales.

And it’s not done, either, with a strong product pipeline that includes cancer drug Keytruda. The pipeline could open avenues to much bigger revenue after a very nice showing so far in 2017. The marriage of so-called “maintenance” drugs to provide regular revenue will fuel dividends now, and new drugs could yield continued dividend growth going forward.

With one of the biggest and most stable brands in medicine, this healthcare stock is a great long-term play for dividend investors. The healthcare company has paid consistent dividends since 1970, and is a rock-solid bet for the coming year.

Dividend Stocks to Buy Now: Procter & Gamble (PG) Why PG Stock Quietly Became a Buyinvestorplace.com/wp-content/uploads/2016/04/pgmsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/pgmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/pgmsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/pgmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/pgmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/pgmsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/pgmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/pgmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/04/pgmsn-91×50.jpg 91w,https://investorplace.com/wp-content/uploads/2016/04/pgmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/pgmsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/04/pgmsn.jpg 728w” sizes=”(max-width: 300px) 100vw, 300px” />Source: Mike Mozart via Flickr (Modified)
Sector: Consumer staples Market Cap: $1225 billion Yield: 3.1% YTD Return: 6% vs. 17% for the S&P 500

You couldn’t have a list of safe-haven investments without Procter & Gamble Co (NYSE:PG), one of the most reliable consumer names on the planet.

Powered by amazing brands from Dawn dish soap to Gillette shaving products to Crest toothpaste, P&G has its fingerprints all over the typical household. And best of all for low-risk investors, these products will keep selling no matter what the macro picture is like because people still need to clean their bodies and their kitchens regardless of where the S&P is headed.

It also has a consistent commitment to dividends, increasing its payout for the last 60 straight years, and has been generous with those increases to boot; distributions have roughly doubled in the last decade, meaning P&G dividend hikes are in the ballpark of 10% each year.

Yes, shares have been rangebound for a few years now. But a recent proxy fight with activist investor Nelson Peltz has shaken the company awake. And even if the tally in the voting has been disputed by P&G, the message from its investors is crystal clear: pay more attention to the bottom line and to delivering real shareholder value. That should usher in some important changes that help this stock remain dominant as we enter 2018.

As of this writing, Jeff Reeves did not have a position in any of the aforemen